The bone bridge protein, SPP1, is a key ECM protein involved in tumor progression and metastasis (33) that is highly expressed in non-small cell lung cancer tissues (34), significantly upregulated in glioma and hepatocellular carcinoma cell lines, and associated with poor prognosis (35, 36). This evidence concerns the gene SPP1 and neoplasm.